These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 31377983)
21. TGIF2 is a potential biomarker for diagnosis and prognosis of glioma. Zhang W; Zhang L; Dong H; Peng H Front Immunol; 2024; 15():1356833. PubMed ID: 38629068 [TBL] [Abstract][Full Text] [Related]
22. An integrated transcriptomic and computational analysis for biomarker identification in human glioma. Xing W; Zeng C Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173 [TBL] [Abstract][Full Text] [Related]
23. CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms. Krug S; Kühnemuth B; Griesmann H; Neesse A; Mühlberg L; Boch M; Kortenhaus J; Fendrich V; Wiese D; Sipos B; Friemel J; Gress TM; Michl P Endocr Relat Cancer; 2014; 21(6):879-90. PubMed ID: 25248790 [TBL] [Abstract][Full Text] [Related]
24. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance. Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226 [TBL] [Abstract][Full Text] [Related]
25. p113 isoform encoded by CUX1 circular RNA drives tumor progression via facilitating ZRF1/BRD4 transactivation. Yang F; Hu A; Guo Y; Wang J; Li D; Wang X; Jin S; Yuan B; Cai S; Zhou Y; Li Q; Chen G; Gao H; Zheng L; Tong Q Mol Cancer; 2021 Sep; 20(1):123. PubMed ID: 34579723 [TBL] [Abstract][Full Text] [Related]
26. PLEKHG5 is a novel prognostic biomarker in glioma patients. Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383 [TBL] [Abstract][Full Text] [Related]
27. Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis. Yang J; Liao D; Wang Z; Liu F; Wu G J Surg Res; 2011 Jun; 168(1):97-102. PubMed ID: 20036387 [TBL] [Abstract][Full Text] [Related]
29. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas. Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811 [TBL] [Abstract][Full Text] [Related]
30. Over-Expressed FEZF1 Predicts a Poor Prognosis in Glioma and Promotes Glioma Cell Malignant Biological Properties by Regulating Akt-ERK Pathway. Yu M; Yu S; Xue Y; Yu H; Chen D; Wei X; Liu Y J Mol Neurosci; 2018 Aug; 65(4):411-419. PubMed ID: 30030762 [TBL] [Abstract][Full Text] [Related]
31. Nucleolar and spindle-associated protein 1 is a tumor grade correlated prognosis marker for glioma patients. Zhu T; Xie P; Gao YF; Huang MS; Li X; Zhang W; Zhou HH; Liu ZQ CNS Neurosci Ther; 2018 Mar; 24(3):178-186. PubMed ID: 29336114 [TBL] [Abstract][Full Text] [Related]
32. WTAP Expression Predicts Poor Prognosis in Malignant Glioma Patients. Xi Z; Xue Y; Zheng J; Liu X; Ma J; Liu Y J Mol Neurosci; 2016 Oct; 60(2):131-6. PubMed ID: 27370540 [TBL] [Abstract][Full Text] [Related]
33. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas. Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009 [TBL] [Abstract][Full Text] [Related]
34. RIZ1: a potential tumor suppressor in glioma. Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953 [TBL] [Abstract][Full Text] [Related]
35. Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas. Bourkoula E; Mangoni D; Ius T; Pucer A; Isola M; Musiello D; Marzinotto S; Toffoletto B; Sorrentino M; Palma A; Caponnetto F; Gregoraci G; Vindigni M; Pizzolitto S; Falconieri G; De Maglio G; Pecile V; Ruaro ME; Gri G; Parisse P; Casalis L; Scoles G; Skrap M; Beltrami CA; Beltrami AP; Cesselli D Stem Cells; 2014 May; 32(5):1239-53. PubMed ID: 24375787 [TBL] [Abstract][Full Text] [Related]
36. TGIF1 overexpression promotes glioma progression and worsens patient prognosis. Wang B; Ma Q; Wang X; Guo K; Liu Z; Li G Cancer Med; 2022 Dec; 11(24):5113-5128. PubMed ID: 35569122 [TBL] [Abstract][Full Text] [Related]
37. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma. Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187 [TBL] [Abstract][Full Text] [Related]
38. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β. Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851 [TBL] [Abstract][Full Text] [Related]
39. Decreased expression of the SPOP gene is associated with poor prognosis in glioma. Ding D; Song T; Jun W; Tan Z; Fang J Int J Oncol; 2015 Jan; 46(1):333-41. PubMed ID: 25351530 [TBL] [Abstract][Full Text] [Related]
40. Molecular profiles for insular low-grade gliomas with putamen involvement. Zhou C; Wang Y; Liu X; Liang Y; Fan Z; Jiang T; Wang Y; Wang L J Neurooncol; 2018 Jul; 138(3):659-666. PubMed ID: 29556911 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]